T. Thybo

Phenotypic Responses to a Lifestyle Intervention Do Not Account for Inter-Individual Variability in Glucose Tolerance for Individuals at High Risk of Type 2 Diabetes

D. O'Gorman, T. Suvitaival, P. Fitzpatrick, 2019, Front. Physiol..

The DEXLIFE study methods: identifying novel candidate biomarkers that predict progression to type 2 diabetes in high risk individuals.

M. Walker, D. O'Gorman, M. Esteller, 2014, Diabetes research and clinical practice.

An evaluation of the DEXLIFE ‘self-selected’ lifestyle intervention aimed at improving insulin sensitivity in people at risk of developing type 2 diabetes: study protocol for a randomised controlled trial

D. O'Gorman, A. Kennedy, G. O’Donoghue, 2015, Trials.